COM:AXSOME
Axsome Therapeutics
- Stock
Last Close
98.19
22/11 21:00
Market Cap
3.92B
Beta: -
Volume Today
425.39K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 2.16M - | 9.73M 350.35% | ||||||||||
average payables | 458.74K - | 1.33M 188.89% | 2.99M 125.37% | 3.76M 25.83% | 3.56M 5.24% | 7.32M 105.41% | 12.22M 67.10% | 13.33M 9.02% | 25.88M 94.18% | 39.64M 53.19% | ||
average receivables | 18.85M - | 66.26M 251.52% | ||||||||||
book value per share | -0.16 - | -0.25 57.93% | -1.57 524.63% | -2.49 58.16% | -3.36 35.23% | -4.00 18.92% | -5.17 29.24% | -7.49 44.93% | -10.88 45.17% | 2.69 124.77% | 0.00 99.84% | |
capex per share | -0.00 - | -0.01 222.95% | -0.00 92.04% | -0.00 179.72% | -0.00 61.04% | -0.00 160.29% | -0.01 562.84% | -0.02 111.24% | ||||
capex to depreciation | -5.70 - | -5.10 10.47% | -0.23 95.44% | -0.67 187.28% | -0.43 35.37% | -0.59 36.73% | -0.27 54.93% | -0.13 52.58% | ||||
capex to operating cash flow | 0.00 - | 0.00 80.98% | 0.00 92.39% | 0.00 190.96% | 0.00 68.05% | 0.00 68.26% | 0.00 385.83% | 0.01 112.06% | ||||
capex to revenue | -0.01 - | |||||||||||
cash per share | 0.16 - | 0.21 25.38% | 4.02 1,853.67% | 1.91 52.45% | 1.49 21.84% | 0.52 65.23% | 6.47 1,144.37% | 4.94 23.57% | 2.30 53.49% | 4.94 114.91% | 0.01 99.83% | |
days of inventory on hand | 303.37 - | 211.94 30.14% | ||||||||||
days payables outstanding | 2.71K - | 569.65 78.99% | ||||||||||
days sales outstanding | 275.00 - | 127.90 53.49% | ||||||||||
debt to assets | 1.82 - | 1.61 11.80% | 0.25 - | 0.28 9.60% | 0.45 60.86% | 0.09 79.89% | 0.27 197.93% | -0.15 154.56% | 0.29 294.42% | 0.32 10.92% | ||
debt to equity | -1.89 - | -1.40 25.80% | -0.20 - | -0.13 36.56% | -0.06 50.45% | -0.11 76.38% | -0.18 58.64% | -0.12 32.43% | 0.86 811.42% | 0.98 12.92% | ||
dividend yield | ||||||||||||
earnings yield | -0.02 - | -0.05 176.95% | -0.10 76.65% | -0.21 120.67% | -0.23 7.89% | -0.41 79.90% | -0.02 95.15% | -0.03 75.43% | -0.09 173.10% | -0.06 33.58% | -0.00 99.90% | |
enterprise value | 112.89M - | 113.02M 0.11% | 62.70M 44.53% | 102.39M 63.31% | 103.39M 0.98% | 68.75M 33.50% | 3.32B 4,723.43% | 2.90B 12.63% | 1.38B 52.22% | 3.03B 118.83% | 3.62T 119,227.69% | |
enterprise value over ebitda | -61.37 - | -41.22 32.84% | -9.06 78.01% | -3.78 58.26% | -3.84 1.40% | -2.11 45.06% | -49.42 2,245.33% | -29.24 40.83% | -11.10 62.03% | -17.72 59.65% | -15.59K 87,886.53% | |
ev to operating cash flow | -69.21 - | -24.59 64.47% | -8.43 65.72% | -4.81 42.92% | -3.91 18.82% | -2.29 41.43% | -71.51 3,025.86% | -36.93 48.36% | -12.79 65.36% | -26.00 103.27% | -24.92K 95,729.65% | |
ev to sales | 60.55 - | 13.36K 21,965.09% | ||||||||||
free cash flow per share | -0.13 - | -0.36 181.80% | -0.62 72.78% | -1.12 78.83% | -1.16 4.17% | -1.12 3.79% | -1.36 21.85% | -2.11 54.73% | -2.89 36.74% | -2.88 0.07% | -0.00 99.89% | |
free cash flow yield | -0.01 - | -0.04 181.80% | -0.07 62.90% | -0.17 145.60% | -0.21 25.56% | -0.40 91.05% | -0.01 96.68% | -0.03 96.30% | -0.08 194.87% | -0.04 51.05% | -0.00 99.89% | |
graham net net | -0.16 - | -0.27 65.47% | 3.80 1,533.97% | 1.04 72.56% | 0.67 36.07% | -0.02 102.64% | 5.24 29,885.22% | 3.00 42.75% | 0.42 86.14% | 0.23 44.61% | 0.00 99.35% | |
graham number | 0.78 - | 1.64 109.14% | 5.59 242.10% | 8.92 59.42% | 9.81 10.02% | 10.18 3.79% | 15.44 51.60% | 21.85 41.56% | 29.63 35.59% | 17.17 42.04% | 0.02 99.87% | |
income quality | 0.75 - | 0.77 1.75% | 0.70 8.03% | 0.78 11.05% | 0.91 16.90% | 0.97 6.12% | 0.68 30.09% | 0.76 12.37% | 0.83 8.85% | 0.62 24.98% | 0.61 2.60% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.21 Infinity% | 0.11 47.39% | |
interest coverage | -5.62 - | -2.54 54.82% | -10.05 295.76% | -207.99 1,969.37% | -20.27 90.26% | -29.14 43.75% | -54.25 86.19% | -38.64 28.78% | -21.89 43.34% | -24.06 9.91% | 35.93 249.29% | |
interest debt per share | 0.33 - | 0.53 61.72% | 0.08 85.50% | 0.52 573.01% | 0.50 3.94% | 0.30 39.62% | 0.62 108.17% | 1.42 127.53% | 1.47 4.00% | 2.51 70.37% | 0.00 99.84% | |
inventory turnover | 1.20 - | 1.72 43.14% | ||||||||||
invested capital | -1.89 - | -1.40 25.80% | -0.20 - | -0.13 36.56% | -0.06 50.45% | -0.11 76.38% | -0.18 58.64% | -0.12 32.43% | 0.86 811.42% | 0.98 12.92% | ||
market cap | 111.16M - | 111.16M 0% | 110.73M 0.38% | 129.27M 16.74% | 127.48M 1.38% | 75.81M 40.53% | 3.52B 4,538.23% | 3.03B 13.80% | 1.42B 53.11% | 3.14B 120.64% | 3.62T 115,194.37% | |
net current asset value | -2.03M - | -3.25M 60.03% | 46.40M 1,529.84% | 21.36M 53.97% | 16.46M 22.93% | 773.74K 95.30% | 178.55M 22,976.35% | 111.68M 37.45% | 15.68M 85.96% | 23.72M 51.33% | 107.00M 351.08% | |
net debt to ebitda | -0.94 - | -0.68 28.00% | 6.94 1,120.80% | 0.99 85.70% | 0.89 10.01% | 0.22 75.79% | 2.98 1,278.06% | 1.35 54.72% | 0.29 78.16% | 0.62 110.67% | 0.86 38.79% | |
net income per share | -0.17 - | -0.47 176.95% | -0.88 87.36% | -1.42 60.68% | -1.27 10.49% | -1.15 9.41% | -2.05 77.84% | -2.83 38.28% | -3.59 26.64% | -4.86 35.61% | -0.01 99.89% | |
operating cash flow per share | -0.13 - | -0.36 181.80% | -0.62 72.31% | -1.11 78.44% | -1.16 4.64% | -1.12 3.86% | -1.36 21.94% | -2.11 54.69% | -2.88 36.43% | -2.87 0.39% | -0.00 99.89% | |
payables turnover | 0.13 - | 0.64 375.92% | ||||||||||
receivables turnover | 1.33 - | 2.85 115.01% | ||||||||||
research and ddevelopement to revenue | 1.16 - | 0.36 68.75% | ||||||||||
return on tangible assets | -1.03 - | -2.15 108.47% | -0.22 90.01% | -0.71 230.84% | -0.81 14.35% | -2.01 147.34% | -0.32 84.31% | -0.57 79.19% | 0.40 170.44% | -0.76 289.62% | -0.46 39.50% | |
revenue per share | 1.23 - | 0.01 99.52% | ||||||||||
roe | 1.07 - | 1.87 75.36% | 0.56 70.00% | 0.57 1.59% | 0.38 33.81% | 0.29 23.82% | 0.40 37.60% | 0.38 4.59% | 0.33 12.76% | -1.81 647.39% | -1.25 30.60% | |
roic | -1.02 - | -2.65 158.56% | 0.55 120.88% | 0.74 34.37% | 0.43 42.64% | 0.36 15.91% | 0.44 22.77% | 0.45 1.80% | 0.36 19.65% | -0.91 353.45% | -0.60 34.31% | |
sales general and administrative to revenue | ||||||||||||
shareholders equity per share | -0.16 - | -0.25 57.93% | -1.57 524.63% | -2.49 58.16% | -3.36 35.23% | -4.00 18.92% | -5.17 29.24% | -7.49 44.93% | -10.88 45.17% | 2.69 124.77% | 0.00 99.84% | |
stock based compensation to revenue | 0.75 - | 0.23 69.31% | ||||||||||
tangible asset value | -2.03M - | -3.20M 57.93% | 46.44M 1,550.22% | 21.57M 53.55% | 16.72M 22.50% | 937.92K 94.39% | 178.72M 18,955.16% | 113.79M 36.33% | -409.20M 459.60% | 39.59M 109.67% | 125.65M 217.41% | |
tangible book value per share | -0.16 - | -0.25 57.93% | 3.89 1,644.02% | 1.13 71.03% | 0.73 34.81% | 0.03 95.25% | 5.25 14,957.87% | 3.06 41.78% | -10.88 455.66% | 0.97 108.95% | 0.00 99.72% | |
working capital | -2.03M - | 1.77M 187.34% | 46.40M 2,519.83% | 30.83M 33.56% | 23.12M 24.99% | 4.39M 81.00% | 195.88M 4,358.85% | 160.59M 18.02% | 63.45M 60.49% | 149.08M 134.95% | 365.41M 145.11% |
All numbers in USD (except ratios and percentages)